Xofigo Injection
Product Images NDC 50419-208

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Xofigo (NDC 50419-208). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

A Kaplan-Meier survival curve comparing the probability of survival over time (in months) between Xofigo and placebo treatment groups. The solid line represents Xofigo and the dashed line represents placebo. Below the graph is a table showing the number of patients at risk in each group at various time points.*

FDA Label Image

Vial Label Nist (Image 02)

Label for Xofigo 30 microcurie/mL (radium Ra 223 dichloride injection) intravenous injection, 6 mL single-dose vial. Manufactured for Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ. Label includes NDC 50419-208-01 and radiation hazard symbol.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.